|
Phil Dolan joined Navicure in 2007. He is responsible for managing the development and execution of Navicure�s marketing strategy.
Mr. Dolan joined Navicure from Merial, LLC, a leading global animal health company jointly owned by Merck and sanofi-aventis. In his five years with Merial, he led growth of the company�s largest profit center, U.S. Parasiticides, from $350 million to more than $700 million in revenue.
Prior to Merial, Mr. Dolan served as Chief Marketing Officer with an early-stage Internet venture in the Washington D.C. area, where he contributed to both revenue growth and capital-raising. He spent the previous eleven years successfully managing flagship brands and categories in progressive marketing and sales leadership roles with Colgate-Palmolive, Heineken and The Coca-Cola Company.
Mr. Dolan graduated from Connecticut College with a bachelor�s degree in Economics and English. | 